- Rating
- 3(+1)
- Confidence
- 2
- Informativeness
- 2
- Presentation
- 3
- Soundness
- 3
Read review
Paper summary
This paper proposes GBM-WAM, an anatomy-guided latent World-Action Model that learns future MRI representations through a Latent World Expert and supervises tumor segmentation and longitudinal changes through a Temporal Mask Expert to improve next-step treatment prediction for glioblastoma. Overall, the paper is clearly written and demonstrates strong experimental performance.
Critical strengths
- This work presents a World Action Model for glioblastoma treatment planning, which carries strong clinical value. Generating costly volumetric MRI also represents a practical challenge in real-world deployment.
- The experimental design is relatively comprehensive with competitive results. The paper includes evaluations on internal and external datasets, experiments across different modality combinations, module ablation studies, and inference efficiency comparisons.
- The model flexibly handles incomplete MRI modalities.
- The manuscript is well-written with clear figures and tables, making it easy to follow.
Critical weaknesses
-
Here is a concern regarding the “world action model”. The model does not seem to produce next observations. Instead, it leverages future MRI prediction during training to optimize latent states, while directly outputting treatment plans via the Action Head at inference time. Given that future tumor simulation is optional at inference and appears to serve primarily as an auxiliary supervision objective for the VLA model during training, what fundamentally distinguishes the proposed approach from conventional VLA methods augmented with future prediction losses?
-
Where is the anatomy-guided component manifested? Is it via segmentation loss, or other mechanisms? Or does it refer to the 3D representations extracted from NeuroVFM? How does this anatomy-guided design specifically affect the action output?
-
What is the distribution of the five treatment categories across the internal and external test sets? Per-class classification performance should be reported, especially the accuracy for the tail categories.
-
The claim about modeling “longitudinal disease progression dynamics” is not well supported by metrics computed in the latent space. Latent representations may blur fine-grained details and primarily reflect static spatial information, the dynamic progression of tumor regions cannot be accurately quantified in this manner.
-
The overall approach appears to be an incremental combination of existing techniques, and the core novelty is not sufficiently prominent.
Questions for authors
The authors need to more clearly define Joint World Action Modeling with VLA and provide more convincing evidence. Please also respond to other questions regarding the methodology and datasets. I would be very happy to raise the score if the rebuttal is reasonable.
4 comments
Rebuttal by Authors (2/2)
[W2] How anatomical guidance reaches the action query
Thank you for asking how anatomical guidance influences treatment planning. In GBM-WAM, anatomical guidance is provided by the temporal mask expert, which complements the latent world objective by supervising tumor anatomy at the current and follow-up visits. To answer your question directly: "anatomy-guided" refers to the segmentation and change losses applied through the mask queries, not to the NeuroVFM representations. The frozen NeuroVFM encoder supplies general 3D MRI features in every configuration, including the variant without mask supervision.
During training, the current and future mask query states modulate a shared decoder through adaptive group normalization, using current MRI features for both time points. The mask and change losses push these states to encode anatomical information. Because the queries follow the mask → world → action order, the world queries read the anatomy-supervised mask states, and the action query attends to both groups, so anatomical supervision informs treatment planning through the intermediate query states.
To test these connections, Table C2 compares the submitted order with two matched controls. Reversing the first two groups lets the mask queries read world states while preserving the action query's access to both groups. The parallel control gives each group the same MRI and clinical inputs while blocking information flow between groups.
Table C2. Query order and connectivity on the internal test set.
| Query configuration | Accuracy | F1 | Specificity | Precision |
|---|---|---|---|---|
| Mask → World → Action | 93.2% | 91.6% | 97.5% | 92.0% |
| World → Mask → Action | 92.0% | 90.1% | 96.9% | 90.7% |
| Parallel query groups | 90.8% | 88.5% | 96.2% | 89.2% |
The two controls measure the direction of mask–world information flow and the contribution of connections between query groups, respectively. Reversing the order costs 1.5 F1 points. Removing inter-group connections costs 3.1 points, because the auxiliary losses still shape the shared backbone during training but the action query loses direct access to the mask and world states at inference.
Separately, with the world expert fixed, the mask ablations show that full temporal mask supervision improves internal accuracy from 91.3% to 93.2% and F1 from 89.2% to 91.6%. Together, the mask ablations and the query controls show both that anatomical supervision contributes and how its information reaches the action predictor.
In the revised manuscript, we have clarified in Section 3.4 how mask supervision shapes the query states and how those states are accessible to the action query, and added the query-order controls in Section 4.4.
[W3] Class support and tail performance
Thank you for requesting the treatment-category distribution and per-class performance. The distribution of each source cohort and of both test sets is reported in Appendix A of the original manuscript. For per-class performance, because Reviewer yXax [W3] asked for the same analysis, we answer both in Shared Response 2, which reports the row-normalized confusion matrices for all five categories, including the tail categories (Tables S3 and S4). These matrices have been added to Appendix D of the revised manuscript.
[W4] Evidence for localized disease progression
Thank you for highlighting the distinction between latent agreement and localized anatomical progression. We agree it is central to our progression claim. Because Reviewer yXax [W2] raised the same point, we answer both in Shared Response 1. It restricts the latent comparison to the tumor region and stratifies it by treatment category and follow-up interval (Tables S1 and S2).
In the revised manuscript, we have clarified the scope of the tumor-region analysis and its relationship to the progression claim in Appendix D.
[1] Yuan et al. Fast-WAM: Do World Action Models Need Test-time Future Imagination? 2026.
[2] GigaWorld Team et al. GigaWorld-Policy-0.5: A Faster and Stronger WAM Empowered by AutoResearch. arXiv:2607.13960, 2026.
[3] Kondepudi et al. Health system learning enables generalist neuroimaging models. 2026.
Dear Reviewer qotw,
Thank you again for your constructive suggestions!
With two days remaining in the discussion period, we would be grateful if you could review our updated response and share your feedback. We have clarified GBM-WAM’s distinction from a VLA with auxiliary losses and added query-connectivity controls to demonstrate how anatomical and world states contribute to treatment prediction. We have also highlighted the technical novelty and provided tumor-region evaluation and per-class confusion analyses.
Please let us know if any points need further clarification. Thank you for your time and consideration!
Best regards,
Authors of Paper 38881
Thank you for the authors’ response. I have considered adjusting my score.
Rebuttal by Authors (1/2)
We sincerely thank you for finding the paper clearly written, and for recognizing its strong clinical value, the practical challenge of generating volumetric MRI, the flexible handling of incomplete MRI modalities, and the relatively comprehensive experimental design.
[W1 & W5] The distinction from a VLA and the technical novelty
Thank you for your careful reading and for identifying the training–inference distinction. GBM-WAM is an early query-based exploration of world-action modeling for GBM treatment planning, connecting anatomy-guided future MRI representation learning with direct treatment planning. While WAMs have been extensively explored for embodied control, our work investigates this paradigm for partially observed, high-dimensional 3D MRI and limited longitudinal treatment records.
During training, future MRI latents and tumor masks supervise intermediate world and anatomical states. At inference, the action query retains access to these supervised states for direct treatment planning, while auxiliary decoding and flow integration are bypassed. Table C1 summarizes how this relates to VLA and WAM approaches.
Table C1. Comparison of action-prediction designs.
An action-only VLA predicts directly from observation and language, giving an efficient decision path without a future-state objective. An explicit-generation WAM additionally models future observations, but its generation step adds inference cost. GBM-WAM combines these strengths: it learns from future MRI and anatomical targets during training, then uses the supervised query states for direct prediction. This matters for 3D MRI, where explicitly generating a future volume is expensive (27.7 s vs. 0.375 s per case in our latency measurements).
This training–inference split follows a direction that recent WAMs are also taking. Fast-WAM [1] and GigaWorld-Policy-0.5 [2] keep future visual supervision during training and omit future-video generation at inference. Both, however, start from a pretrained video world model. No comparable pretrained world model is available for volumetric MRI, where the data are 3D, multi-sequence, often incomplete, and longitudinally scarce. Bringing the WAM idea to GBM therefore requires building the world learning itself, and each component of GBM-WAM answers one obstacle in doing so.
First, generating a 3D volume is costly, so we predict the future in the latent space of an MRI-specific encoder (NeuroVFM [3]). Second, patients rarely have every sequence, so flow matching with sequence-specific MoT branches predicts the complete multi-sequence future from whichever sequences are available. Third, the tumor occupies a small part of the volume, so current-mask, future-mask, and change supervision direct the states toward the anatomy that matters. Finally, these supervised states are not discarded after training. Under the mask → world → action order, the action query reads them at inference. This is what distinguishes GBM-WAM from a VLA trained with auxiliary future-prediction losses, where such losses only shape the shared backbone. We tested this distinction directly. The parallel-query control in the following Table C2 is such a model: it keeps the same backbone and the same world and mask losses, but the action query cannot read the mask and world states. It reaches 88.5% F1 and 90.8% accuracy, versus 91.6% and 93.2% for GBM-WAM, so 3.1 F1 points come from the action query's access to the supervised states rather than from the auxiliary losses alone. We also note that GBM-WAM can still produce the next observation when needed: future MRI latents and masks can be decoded on demand (27.7 s per case), and only the default treatment planning path skips this step. Manuscript Table 3 shows that each step adds to treatment planning: F1 rises from 85.9% with direct latent regression to 87.8% with flow matching, 89.2% with MoT branches, and 91.6% with temporal mask supervision.
In the revised manuscript, we have added a new Appendix F, which presents this comparison (Table C1) and distinguishes the query states retained at inference from auxiliary decoding and flow integration.